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Presentation of clinical case
The patient is at present a 9 year old boy who is the second
child of non-consanguineous parents who are of British and
Romany origin.He was born at full-term, by a normal delivery
after an uncomplicated pregnancy, with a birth weight of 3.5 kg.
At 2 months of age he had dyspnoea and stridor, but no
seizures and at 12 months of age he sustained a right forearm
fracture following minimal trauma. He did not suffer from re-
peated infections, and did not have facial dysmorphology, deaf-
ness or cardiac lesions.He was not mentally retarded and at-
tained developmental milestones without delay.His growth
continued on the 50th centile. At the age of 3.5 years he devel-
oped carpo-pedal spasms, and investigations revealed
hypocalcaemia [serum corrected calcium concentration = 1.44
mmol/L (normal2.20-2.65 mmol/L)], hyperphosphataemia
[phosphate = 3.21 mmol/L (normal 1.29-1.78 mmol/L)], and an
undetectable circulating PTH concentration (<10 ng/L).O t h e r
serum measurements, which included sodium, potassium,
urea, creatinine, liver function tests, magnesium and fasting
glucose were all normal.He was noted to have dystrophic nails
at this time, and subsequently developed alopecia areata,
which progressed to alopecia totalis by the age of six years
(Figure 1).Thyroid function and synacthen tests have been
normal, and an assessment for autoantibodies that included
those for anti-nuclear, anti-parietal, anti-smooth muscle, anti-
mitochondrial, anti-reticulin, anti-adrenal, anti-insulin, anti-thy-
roglobulin, anti-peroxidase and anti-parathyroid antibodies was
negative.
Haemoglobin and MCV were also normal.There was no histo-
ry of neck surgery or trauma and there was no family history of
autoimmune related diseases, and in particular hypoparathy-
roidism, alopecia, vitiligo, or Addison’s disease. Examination
revealed him to have dystrophic nails, consistent with monilia-
sis, and alopecia (Figure 1).There were no other abnormalities
and in particular there was an absence of vitiligo, cataracts, ec-
topic calcification, dental caries, enamel hypoplasia, and
b r a c h y d a c t y l y .Renal ultrasonography revealed that both kid-
neys were of normal size and architecture.
Treatment with 1a-hydroxycholecalciferol (alfacalcidol) re-
stored normocalcaemia and he has not suffered further from
carpo-pedal spasms or seizures.The clinical diagnosis was
therefore of hypoparathyroidism due to autoimmune polyen-
docrinopathy syndrome (APS) type 1, and to further confirm
this, mutational analysis of the autoimmune regulator 1 (AIRE-
1) gene was undertaken.
Methods
Venous blood was obtained after informed consent, from the
proband and his parents, using guidelines approved by the lo-
cal ethical committee, and used to extract leukocyte DNA (1).
Fourteen pairs of gene-specific oligonucleotide primers were
employed for the PCR amplification of the 14 coding exons and
adjoining splice junctions of the AIRE-1 gene using methods
previously described (2).The DNA sequences of the resultant
PCR products were determined by the use ofThermoSeque-
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Figure 1 - Signs of APS1 in the patient.Panels A-D showing progres-
sion of hair loss from normal hair distribution at age3 years (panelA) to
alopecia areata (panel B) at age 5 years and ultimately to alopecia to-
talis (panels C andD) by age 6 years.Note also the progressive loss of
eyebrows over this time period.P a n e lE shows dystrophic and hy-
poplastic finger nails, consistent with moniliasis.
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nase IIDNA polymerase dye terminator cycle sequencing
(Amersham Pharmacia Biotech Inc, Little Chalfont, Bucks, UK)
and a semi-automated detection system (ABI 373 sequencer,
Applied Biosystems,F o s t e rCity, CA,USA) as previously de-
scribed (3).DNA sequence abnormalities were confirmed ei-
ther by restriction enzyme analysis or by agarose gel elec-
trophoresis as previously reported (2, 4).
Results
DNA sequence analysis of the entire 1635 bp coding region and
26 exon/intron boundaries of the A I R E - 1 gene in the patient re-
vealed the presence of two mutations.These consisted of a ma-
ternally inherited nonsense mutation (Arg257Stop) in exon 6
(Figure 2) and a paternally inherited 13 bp deletion in exon 8
(Figure 3).Thus, the patient with APS1 has 2 different A I R E -1
mutations and hence is a compound heterozygote.The sole oc-
currences of theArg257Stop mutation in the unaffected mother
(Figure 2) who is of Romany origin, and the 13 bp deletional
frameshift in the unaffected father, who is of British origin, are
consistent with the autosomal recessive inheritance ofA P S1 .
Discussion
Our studies of a patient withAPS1 have identified two A IR E - 1
mutations, which consisted of a maternally inherited nonsense
mutation (Arg257Stop), and a paternally inherited 13 bp dele-
tional frameshift.The AIRE-1 gene encodes a 545 amino acid
protein (4), that contains:2 plant homeodomain (PHD) zinc fin-
ger motifs (codons 298-343, and codons 433-478); 4 LXXLL mo-
tifs (codons 7-11, 63-67, 414-418, and 516-520); and a proline
rich domain in exon 10 (codons 366 to 426) (4-6). The 2 A I R E - 1
mutations (Figures 2 and 3) identified in the patient withA P S 1
(Figure 1) are predicted, if translated, to result in truncated forms
of the protein.Thus, the Arg257Stop mutation would result in a
256 amino acid peptide that lacks the2 PHD zinc finger do-
m a i n s ,2 of the 4 LXXLL domains, and the proline rich domain.
T h e13 bp deletional-frameshift would result in a 372 amino acid
peptide that contained 50 missense C-terminal amino acids, a
disrupted first PHD zinc finger domain, and a lack of the second
PHD zinc finger domain together with2 of the 4 LXXLL domains
and the proline rich region.These truncated A I R E - 1 proteins are
likely to be inactive, and it has been shown with the use of tran-
scriptional reporter assays, that the Arg257Stop mutation leads
to a loss of transcriptional transactivation activity (7).In addition,
deletion constructs lacking the PHD zinc finger domains have
been shown to have grossly disordered sub-cellular localization
( 8 ) .Thus, the 2 mutations identified in this patient withAPS1 are
likely to result in a loss of transcriptional activity.
The 13 bp deletional framshift and the Arg257Stop mutations
are the most frequently occurring mutations in the British, and
the Central and Eastern European populations, respectively (2,
9, 10), and this is consistent with the British andR o m a n y
parentage of the patient withA P S 1 . The 13 bp deletional
frameshift has increased prevalences of 70% and 53% in the
genetically outbred British and NorthAmerican populations, re-
spectively, when compared to the world prevalence of 23% (2,
10-12). This would seem to suggest that there is not only a
founder effect but also a recurrence of the same mutation and
it is important to note that the region of the mutations is flanked
by repetitive DNA sequences.The heterozygous carrier rate of
this mutation in the British population has been estimated to be
1/576 (2), and several mechanisms, that include slipped-strand
mispairing and formation of hairpin structures from the imper-
fect inverted repetitive sequence, have been proposed for the
increased susceptibility for mutagenicity (2, 5).
It is interesting to note that APS1 is unusual among diseases
caused by transcription factor mutations in that it requires both
alleles to be inactivated in order to produce a disease pheno-
type.This is in contrast to the situation seen with the develop-
ment of the hypoparathyroidism, deafness and renal dysplasia
(HDR) syndrome which is due to haploinsufficiency of the tran-
scription factor GATA3 (13, 14).This may be related to a gene
dosage effect, whereby the wild-type allele is able to compen-
sate for the loss of function due to the mutant in the case of
AIRE-1 but not in the case of GATA3.
Finally, the monogenic aetiology of APS1 makes it a unique
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Figure 2 - Maternally inherited AIRE-1 nonsense mutation inAPS1 pa-
tient, detected by restriction enzyme analysis.DNA sequence analysis
of the patient (II-1) revealed a C® T transition at codon 257, in exon 6,
thereby altering the wild-type (WT) sequence CGA encoding an argi-
nine (Arg) to the mutant (m) sequence,T G A ,encoding a termination
signal (Stop) (A).This nonsense mutation,Arg257Stop, also resulted in
a loss of a Taq I restriction enzyme site (T/CGA) and this facilitated the
detection of the mutation (B).Following PCR amplification and Taq 1 i-
gestion one product of135 bp is obtained from the m sequence, but
two products of 61 bp and 74 bp are obtained from theWT (normal) se-
quence (C).The patient and his unaffected mother (I-2) are heterozy-
gous (WT-m), for the wild-type and mutant sequences, whilst the unaf-
fected father (I-1) is homozygous for the wild-type sequence.The muta-
tion was absent from110 alleles of 55 unrelated normals (N1 shown),
consistent with it not being a common DNA sequence polymorphism.
Individuals are represented; males as squares, females as circles, un-
affected as open symbols and affected as filled in symbols.A standard-
size marker (S), in the form of a 1 Kb ladder, is shown.
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model for studying the biological events leading to autoimmuni-
ty and autoimmune diseases (15). Several major autoantigens,
inAPS1, have been identified, and these include the P450 en-
zymes 17a -hydroxylase, 21-hydroxylase and side chain cleav-
age enzyme (16-18).Tissue-specific autoimmune targets have
also been reported, including thyroid peroxidase, thyroglobulin,
insulin, liver specific P450 enzymes and melanocyte transcrip-
tion factors (SOX9 and SOX10) (19).The in vivo effects of
AIRE-1 loss have been studied in mice deleted for AIRE-1, and
homozygous (-/-) null mice were found to develop normally, but
to exhibit features of APS1 including multiorgan lymphocytic in-
filtration, circulating autoantibodies and infertility (20).F u r t h e r
studies in such mice have demonstrated that AIRE deficiency
causes an almost complete failure to delete organ-specific cells
in the thymus, and thus APS1 is likely to be caused, at least in
part, by a failure of the negative selection of forbidden organ-
specific T cells in the thymus (21).
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Figure 3 - Paternally inherited AIRE-1 deletional mutation inAPS1 pa-
tient, detected by agarose gel electrophoresis.DNA sequence analysis
of the patient (II-1) revealed a 13 bp deletion (del 13 bp) at nucleotide
(nt) 967-979 (codon 322 - 326), in exon 8 (A).The deletion results in a
frameshift (indicated by underlined sequence and an arrow) that leads
to the incorporation of 50 missense amino acids after which a prema-
ture termination signal (Stop) (TAA) is encountered. The 13 bp deletion
results in the formation of heteroduplex (WT/m) and homoduplexes
(WT/WT and m/m) that can be detected by agarose gel electrophoresis
( B ) .Thus, the mutant (m) PCR product is 216 bp, whereas theWT
product is 229 bp (C) and a heteroduplex is observed at approximately
250 bp.The patient (II-1) and his unaffected father (I-1) are heterozy-
gous (WT/m), for the wild-type and mutant sequence, whilst the unaf-
fected mother (I-2) is homozygous for the wild-type sequence.The 13
bp deletion was absent from110 alleles of 55 unrelated normals (N1
shown), consistent with it not being a commonDNA sequence polymor-
p h i s m .The symbols representing the individuals are as described in
Figure 2.A standard-size marker (S), in the form of a 1 Kb ladder, is
shown.
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